Magazine Article | February 1, 2022

Do Patients Really Want Hybrid Clinical Trials?

Source: Life Science Leader

By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical

COVID-19 has created a public that is more educated than ever before on vaccine development and the need for clinical research. That’s why Ken Getz was so surprised to learn that, according to his organization’s research, the pandemic did not have a measurable impact on the attitudes and perceptions that patients have about clinical trials.

"We saw high ratings in terms of the quality of patients’ experiences in clinical research along with a high willingness to repeat participation,” says Getz, the founder and board chair of the Center for Information and Study on Clinical Research Participation (CISCRP). However, despite the industry shift toward patient-centric practices, “the fundamental measures around the burdens of participation and their influence on the decision to participate only changed slightly.”

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: